Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moira Rachman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drug Discovery Today. Technologies|December 17, 2021
Fragment-to-lead tailored in silico designMoira Rachman, Serena Piticchio, Maciej Majewski, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
<i>In silico</i> analysis of the Chikungunya virus and SARS-CoV-2 MacrodomainVikas Tiwari, Moira Rachman, Kenneth Huang, et al.
Chemmedchem|February 21, 2019
DUckCov: a Dynamic Undocking-Based Virtual Screening Protocol for Covalent BindersMoira Rachman, Andrea Scarpino, Dávid Bajusz, et al.
RSC Medicinal Chemistry|January 22, 2021
Discovery of a novel kinase hinge binder fragment by dynamic undockingMoira Rachman, Dávid Bajusz, Anasztázia Hetényi, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical SpaceSerena G Piticchio, Míriam Martínez-Cartró, Salvatore Scaffidi, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learningGalen J Correy, Moira Rachman, Takaya Togo, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2022
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug Discovery Today. Technologies|December 17, 2021
Fragment-to-lead tailored in silico designMoira Rachman, Serena Piticchio, Maciej Majewski, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
<i>In silico</i> analysis of the Chikungunya virus and SARS-CoV-2 MacrodomainVikas Tiwari, Moira Rachman, Kenneth Huang, et al.
Chemmedchem|February 21, 2019
DUckCov: a Dynamic Undocking-Based Virtual Screening Protocol for Covalent BindersMoira Rachman, Andrea Scarpino, Dávid Bajusz, et al.
RSC Medicinal Chemistry|January 22, 2021
Discovery of a novel kinase hinge binder fragment by dynamic undockingMoira Rachman, Dávid Bajusz, Anasztázia Hetényi, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical SpaceSerena G Piticchio, Míriam Martínez-Cartró, Salvatore Scaffidi, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learningGalen J Correy, Moira Rachman, Takaya Togo, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2022
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Pageof 1